AzTrials
AzTrials

GrowthSaqmoloNCT04316221

Effects of Complementary Feeding of Eggs on Infant Development and Growth in Guatemala: The Saqmolo Study

A study testing Standar of care in people with Growth and Development; Delayed, run by Academy of Nutrition and Dietetics at 1 site in Guatemala.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The specific aims of this study are: In a randomized controlled trial, the investigators will evaluate the impact of daily egg consumption during the complementary feeding period in addition to the local standard of nutrition care (i.e., intervention group), compared to the local standard of nutrition care alone… Read more about this study

Who is it for?
Ages 6 to 9 monthsHealthy volunteers can take part
Conditions the study is for
Growth, Development; Delayed
What is being tested?
Standar of care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,200 participants
Where
1 siteGuatemala
Study dates
1 Apr 2021to 30 Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 9 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Infants who are 6.0-9.0 months of age at baseline
  • At least one caregiver willing to provide oral informed consent
  • Planned residence in the study area for approximately the next 18 months
  • Singleton birth

Who cannot join

  • Infants with moderate to severe acute malnutrition (weight-for-length z-score < -2)
  • Infants with severe anemia (Hgb <7 g/dL per WHO guidelines, with adjustments for altitude as necessary)
  • Infants with a chronic medical condition that affects growth (e.g., congenital heart disease, genetic condition) as determined by the MHA staff physician
  • Infants whose caregivers have cognitive or other impairments that prevent them from being able to provide informed consent or to reliably provide information required for the developmental assessments
  • Infants with a known egg allergy
  • Infants with recalcitrant, moderate-to-severe atopic dermatitis
  • Infants with a history of anaphylaxis or serious allergic reaction to any substance requiring emergency medical care
  • Concurrent participation in any other clinical trial

Trial locations and contacts

1 site in 1 country.

Guatemala1 site
  • Wuqu' Kawoq/Maya Health Alliance

    Tecpán Guatemala, Departamento de Chimaltenango

Other trials in Guatemala

About this study

Official title: The Effects ofComplementary Feeding of Eggs on Infant Developmentand Growth in Guatemala: The Saqmolo Study

The specific aims of this study are:

In a randomized controlled trial, the investigators will evaluate the impact of daily egg consumption during the complementary feeding period in addition to the local standard of nutrition care (i.e., intervention group), compared to the local standard of nutrition care alone (i.e., control group) on the following outcomes, in infants that are ~6-month old at baseline:

Read more
  1. Child development, as measured by global development scores (primary outcome)
  2. Growth, as measured by anthropometrics (secondary outcome)
  3. Diet quality, as measured by the World Health Organization infant and young child feeding indicators (secondary outcome)

Hypothesis: The investigators hypothesize that daily consumption of eggs during the complementary feeding period, in addition to the local standard of nutrition care, will improve child development, growth, and diet quality compared to the local standard of care alone.

Read the detailed description

Background: Approximately 150 million children, or roughly one-quarter of children worldwide, experience stunting (low height-for-age), while 20% are underweight.1 World-wide, undernutrition is estimated to be responsible for 2.2 million deaths and 21% of Disability-Adjusted Life Years (DALYs) in children less than 5 years of age. 1 The recent United Nations Sustainable Development Goals call for reducing stunting and wasting in children <5 years by 40%, which would affect 90 million children worldwide 1.

The global attention to stunting is based on the premise that any intervention aimed at improving linear growth may subsequently lead to improvements in the correlates of stunting 2. In children, stunting is consistently associated with poor developmental outcomes3. However, optimal interventions to concurrently address stunting and child development still need to be identified3-9.

In Guatemala, stunting is a serious public health problem10,11. The overall prevalence of stunting in children under 5 years of age in Guatemala is close to 50% and is even higher (close to 70%) for indigenous children12. The majority of indigenous families in Guatemala live on less than $2 (USD) per day and have inadequate access to health and nutrition services.

Wuqu' Kawoq-Maya Health Alliance (MHA) (http://www.wuqukawoq.org) is a non-governmental organization, located in Tecpán, Guatemala, working with vulnerable indigenous communities to provide culturally and linguistically appropriate healthcare services. MHA is currently collaborating with the Academy of Nutrition and Dietetics/UNM on projects to address malnutrition in rural Guatemala.

This study will specifically focus on evaluating the impact of regular egg consumption from about 6-12 months of age, in addition to the local standard of nutrition care, as an intervention to improve development, growth and diet quality in Mayan children. Eggs are a rich source of nutrients important to child growth and development: essential fatty acids, choline, vitamins A, and B12, and bioavailable iron, zinc and iodine13. Individual components of eggs may be associated with improved cognitive development in healthy populations, as recently reviewed by Wallace14. Eggs are culturally acceptable as part of the typical Mayan diet, are generally more affordable than other animal-source foods and are relatively simple to store and prepare15. A recent study found that egg consumption (1 egg/d for 6 months) reduced stunting in mixed-indigenous rural Andean children in Ecuador by 47% (HR: 0.53; 95% CI: 0.38-0.88);16 however, child cognitive development was not assessed in this small intervention study. This study will address a gap in understanding the impact of egg consumption, combined with other common interventions to address undernutrition in low- and middle-income settings, on both child development and growth.

Study Design: This is a randomized controlled trial involving children ages ~6 to 12 months from communities in central Guatemala within Wuqu' Kawoq's catchment area (departments of Chimaltenango, Sololá, Sacatepéquez, Suchitepéquez) individually randomized to either the intervention or control group.

  • The control group will receive the local standard of nutrition care only. The standard of nutrition care in Guatemala includes the following clinical care, as determined to be necessary by the MHA medical and nutrition teams: frequent growth monitoring, general nutrition education, parasite treatment, and multiple micronutrient supplementation.
  • The intervention group will receive an intervention to promote daily egg consumption for a six month period, in addition to the local standard of nutrition care. Specifically, intervention group participants will be provided with enough eggs for the infant to consume one egg, daily, for six months, and also with education on preparation and consumption of eggs.

Subjects and Timeline: The study will enroll 1200 infants into two study groups: intervention (n=600 children) and control (n=600 children). The study is powered to detect a difference in effect size of 0.15 for growth, assuming a 20% attrition rate over the course of the six month study. The investigators used a smaller effect size than found in previous relevant literature, because the control group in those studies did not also receive the clinical care that is part of standard of nutrition care in Guatemala, as will be the case in this study.

This study will use a rolling recruitment approach. Approximately 40 infants per month will be enrolled into each study group. The investigators anticipate 15 months of rolling recruitment, with final subjects finishing the study at ~21 months after beginning recruitment. The expected total duration of the study, including data analysis and dissemination, is approximately 3 years from the date of IRB approval.

Individual participants and their caregivers will have approximately 10-12 hours of contact with the research team over about 6 months:

  • Study enrollment (visits to recruit, assess eligibility, and complete the informed consent process) is anticipated to take ~total 2 hours.
  • The primary study data collection time points will be at 0 months (baseline) and 6 months (end of standard of care/egg intervention). It is anticipated that each of these study data collection visits will last approximately 1-2 hours (~total 2-4 hours).
  • All participants will have six ~60 minute visits with MHA field staff (~total 6 hours). At those visits, all participants will receive the nutrition standard of care and be screened for development of an egg allergy. The intervention group will also receive eggs and egg related education, and answer brief questions about adherence.

Research Setting: The study will be conducted with communities in Wuqu' Kawoq's catchment area (departments of Chimaltenango, Sololá, Sacatepéquez, Suchitepéquez) in central Guatemala. The primary language spoken in this area is Kaqchikel. MHA has been providing primary care and nutrition services in this area for over a decade and collaborates closely with Ministry of Health staff and multiple other non-governmental organizations in the region.

All recruitment, enrollment and study-related procedures will be conducted in the homes of the subjects. All study procedures will be conducted by MHA staff. The study will be locally overseen and approved by MHA's IRB.

Being tested
Eggs plus standard of care, Standar of care
Keywords
Eggs, nutrition, growth stunting, infant development

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Eggs plus standard of careDietary supplement

    Eggs will be secured locally and delivered to families weekly.

  • Standar of careOther

    frequent growth monitoring, general nutrition education, parasite treatment, and multiple micronutrient supplementation.

Study groups in NCT04316221
Study groupRoleWhat they receive
ControlActive comparatorThe standard of nutrition care in Guatemala includes the following clinical care, as determined to be necessary by the MHA medical and nutrition teams: frequent growth monitoring, general nutrition education, parasite treatment, and multiple micronutrient supplementation.
Receives: Other: Standar of care
InterventionExperimentalThe intervention group will receive an intervention to promote daily egg consumption for a six month period, in addition to the local standard of nutrition care. Specifically, intervention group participants will be provided with enough eggs for the infant to consume one egg, daily, for six months, and also with education on preparation and consumption of eggs.
Receives: Dietary Supplement: Eggs plus standard of care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Caregiver Reported Child Development Instruments (CREDI)

    The long form CREDI uses caregiver report and captures five domains: motor, language, cognition, social-emotional, and mental health. The CREDI is designed specifically to measure normal development within populations and has been tested in high, middle and low income countries The CREDI included a Guatemalan sample in the validation

    Measured: 6 months

  2. Guide for Monitoring Child Development (GMCD)

    The GMCD has been used in low- and middle-income countries in children ages 0-24 months and focuses on seven areas: expressive language, receptive language, fine motor, gross motor, relating, play, and self-help.

    Measured: 6 months

Secondary outcomes (5)
  1. changes in infant hemoglobin

    Point-of-care hemoglobin will be assessed using a capillary blood sample obtained from the infant's heel or finger and a HemoCue® Hb201+ promo (HemoCue AB, Angelholm, Sweden).

    Measured: 6 months

  2. weight-for-age

    weight as appropriate for chronological age. Weight will be monitored using a hanging Salter scale to the nearest 0.1 kg.

    Measured: 6 months

  3. length-for-age

    Infant length will be measured using a portable stadiometer to the nearest 1 mm.

    Measured: 6 months

  4. Head circumference

    Head circumference will be measured using non-stretchy measuring tape to the nearest 1 mm.

    Measured: 6 months

  5. Infant diet quality

    Infant diet quality will be measured using the World Health Organization Infant and Young Child Feeding indicators questionnaire

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Mar 2020
  2. Study start1 Apr 2021
  3. Primary completion30 Sep 2023
  4. Study completion30 Sep 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a randomized controlled trial involving children ages \~6 to 12 months from communities in central Guatemala within Wuqu' Kawoq's catchment area individually randomized to either the intervention or control group.
Masking
Single blind
Who is masked
Investigator
Enrolment
1,200 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04316221
Sponsor's protocol ID
AcademyND
Acronym
Saqmolo
Status last verified
Mar 2026
First submitted
16 Mar 2020
Last updated
13 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Standar of care in people with Growth and Development; Delayed, run by Academy of Nutrition and Dietetics at 1 site in Guatemala.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Guatemala. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Caregiver Reported Child Development Instruments (CREDI) (time frame: 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in